Hispolon inhibition of inflammatory apoptosis through reduction of iNOS/NO production via HO-1 induction in macrophages

J Ethnopharmacol. 2014 Oct 28:156:61-72. doi: 10.1016/j.jep.2014.07.054. Epub 2014 Aug 14.

Abstract

Ethnopharmacological relevance: Phellinus linteus (Berkeley & Curtis), a well-known medical fungus, has long been used as a traditional medicine in Oriental countries to treat various diseases, and hispolon (HIS) is one of its bioactive components. HIS is known to possess potent antineoplastic and antiviral properties; however, its effect on inflammatory apoptosis is still undefined.

Materials and methods: RAW264.7 macrophages were incubated with HIS for 30 min followed by LPS, LTA, or PGN stimulation for 12h. The expression of indicated proteins AP-1 and NF-κB transcriptional activities was examined by Western blotting using specific antibodies. Levels of NO and ROS were examined by Griess reaction, and DCHF-DA staining via flow cytometric analysis, respectively. AP-1 and NF-κB transcriptional activities were detected by luciferase reporter assay. Knockdown of HO-1 protein expression was performed by transfection of macrophages with HO-1 siRNA. Pharmacological inhibitors including ROS scavenger NAC, JNK inhibitor SP600125, NF-κB inhibitor BAY117082 were applied for mechanism study.

Results: HIS showed concentration-dependent inhibition of LPS, LTA, and PGN-induced iNOS protein expressions and NO production by RAW264.7 macrophages. Accordingly, HIS protected RAW264.7 cells from LPS-, LTA-, and PGN-induced apoptosis. Increased HO-1 by HIS was detected at both protein and mRNA levels along with an increase in intracellular peroxide, and this was inhibited by the translational inhibitor, cycloheximide (CHX), the transcriptional inhibitor, actinomycin D (Act D), and the reactive oxygen species scavenger, N-acetylcysteine (NAC). A mechanistic study indicated that inhibition of c-Jun N-terminal kinase (JNK) protein phosphorylation, and activator protein (AP)-1 and nuclear factor (NF)-κB activation were involved in the anti-inflammatory actions of HIS in macrophages. A structure-activity relationship analysis showed that HIS expressed the most potent effect of inhibiting iNOS and apoptosis elicited by LPS, LTA, and PGN with a significant increase in HO-1 protein in macrophages.

Conclusions: Evidence supporting HIS prevention of inflammatory apoptosis via blocking NO production and inducing HO-1 protein expression in macrophages is provided, and the hydroxyl at position C3 is a critical substitution for the anti-inflammatory actions of HIS.

Keywords: Apoptosis; Heme Oxygenase-1; Hispolon; Inducible Nitric Oxide Synthase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthracenes / pharmacology
  • Apoptosis / drug effects*
  • Catechols / pharmacology*
  • Dose-Response Relationship, Drug
  • Heme Oxygenase-1
  • Inflammation / metabolism*
  • Lipopolysaccharides / antagonists & inhibitors
  • Macrophages*
  • NF-kappa B / biosynthesis
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitriles / pharmacology
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • Structure-Activity Relationship
  • Sulfones / pharmacology
  • Teichoic Acids / antagonists & inhibitors
  • Transcription Factor AP-1 / biosynthesis

Substances

  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Anthracenes
  • Catechols
  • Lipopolysaccharides
  • NF-kappa B
  • Nitriles
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • Sulfones
  • Teichoic Acids
  • Transcription Factor AP-1
  • hispolon
  • pyrazolanthrone
  • Nitric Oxide
  • lipoteichoic acid
  • Nitric Oxide Synthase Type II
  • Heme Oxygenase-1